Intuitive Surgical, Inc. (ISRG)
Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates Again
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?
Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.
Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $404.27, denoting a +1.14% move from the preceding trading day.
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.
Is Procedure Growth Broad-Based Enough to Support ISRG's 2026 Outlook?
Intuitive Surgical's ISRG raised its full-year outlook on the first-quarter earnings call, primarily supported by a broadly diversified procedure growth profile. The management increased its 2026 da Vinci procedure growth guidance to 13.5-15.5% from 13-15%, reflecting confidence in sustained adoption trends.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 50 Years
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) is positioned for multi-decade compounding because it sits at the center of an aging-world healthcare megatrend with a razor-and-blade business model that compounds quietly whether the broader market is euphoric or fearful.
Intuitive Surgical: A Growth Story You Should Have On Your Radar
Intuitive Surgical stands out from other large cap healthcare companies as a high-growth company and a pure play in very attractive segment of the industry. The seemingly elevated earnings multiple is a cause of concern to many, but it is justified once we account for the overall quality of the business model. International and procedure expansion of ISRG platforms make the highly profitable business model worth considering even at nearly 50 times current earnings.
Intuitive Surgical: Priced For Perfection, But The Growth Isn't Done
Intuitive Surgical has become a more attractive opportunity after a 28% stock decline, prompting an upgrade from Hold to Buy. ISRG operates in a high-growth surgical robotics market, which could nearly triple by 2033, supporting long-term bullishness. Despite a premium valuation, ISRG's consistent top and bottom-line growth and management execution justify its price.
ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?
ISRG placed 431 da Vinci systems in Q1 2026, but rising trade-ins and leasing growth raise questions about whether demand is structural or upgrade-driven.
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
